LQDA

LQDA: earnings, filings and news, read by Graham as they come out.

Reads

• Liquidia Corp has agreed to immediately cease and desist all sales of its infringing Yutrepia product for PH-ILD upon receiving FDA approval for an amended product label that removes the indication. Dodd · LQDA